Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor

NCT: NCT07681375 · ACTIVE_NOT_RECRUITING

NCT IDNCT07681375
StatusACTIVE_NOT_RECRUITING
Start Date2023-04-11
Completion2027-01-15
SponsorDexCom, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the feasibility of the DexBasal Study System

Frequently Asked Questions

What is Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor?

Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor is a clinical trial registered under NCT07681375. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07681375?

The current status of NCT07681375 (Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor) is: ACTIVE_NOT_RECRUITING.

When did Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor start?

Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor started on 2023-04-11.

Related Devices

K252818Dexcom Smart BasalDexcom, Inc. K234070Stelo Glucose Biosensor SystemDexcom, Inc. K260935Stelo Glucose Biosensor SystemDexcom, Inc. K261359Stelo Glucose Biosensor SystemDexcom, Inc. PMA P120005Sensor, glucose, invasiveDexcom, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑